Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice
暂无分享,去创建一个
David P. LeBrun | Michael L. Cleary | G. Barsh | D. LeBrun | M. Cleary | E. Waller | Edmund K. Waller | Mary E. Stevens | Douglas A. Dedera | Anish Sen-Majumdar | Greg S. Barsh | M. Stevens | A. Sen-Majumdar | D. Dedera | Sen-Majumdar Anish | Anish Sen-Majumdar
[1] M. Lieberman,et al. Differentiation of CD3-4-8- thymocytes in short-term thymic stromal cell culture , 1992, The Journal of experimental medicine.
[2] K. M. Abraham,et al. Thymic tumorigenesis induced by overexpression of p56lck. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] David Baltimore,et al. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all , 1990, Cell.
[4] M. Cleary,et al. PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1 , 1991, Molecular and cellular biology.
[5] F. Behm,et al. Different Molecular Consequences of the 1;19 Chromosomal Translocation in Childhood B - Cell Precursor Acute Lymphoblastic Leukemia , 1992 .
[6] T. Kadesch,et al. Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. , 1990, Science.
[7] M. Scott,et al. The structure and function of the homeodomain. , 1989, Biochimica et biophysica acta.
[8] A. W. Harris,et al. The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.
[9] E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. , 1993, Molecular and cellular biology.
[10] C. Murre,et al. A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells , 1993, Molecular and cellular biology.
[11] R. Warnke,et al. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. , 1986, American journal of clinical pathology.
[12] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[13] M. Cleary. Oncogenic conversion of transcription factors by chromosomal translocations , 1991, Cell.
[14] I. Weissman,et al. Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.
[15] I. Weissman,et al. An immunodominant murine lymphoma cell surface heterodimer marks thymic progenitor subsets. , 1990, Journal of immunology.
[16] M. Cleary,et al. Molecular analysis of the t(1;19) breakpoint cluster region in pre‐b cell acute lymphoblastic leukemias , 1990, Genes, chromosomes & cancer.
[17] I. Weissman,et al. IgH enhancer deregulated expression of L‐myc: abnormal T lymphocyte development and T cell lymphomagenesis. , 1990, The EMBO journal.
[18] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[19] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[20] A. Strasser,et al. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.
[21] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[22] David Baltimore,et al. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.
[23] Michael L. Cleary,et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor , 1990, Cell.
[24] T. Rabbitts,et al. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. , 1992, Oncogene.
[25] T. Blankenstein,et al. A retroviral expression vector containing murine immunoglobulin heavy chain promoter/enhancer. , 1988, Nucleic acids research.
[26] J. Sklar,et al. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.
[27] Suzanne Cory,et al. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.
[28] S. Smith,et al. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. , 1989, Science.
[29] J. Tilly,et al. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. , 1992, Molecular endocrinology.
[30] J. Shuster,et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. , 1993, Blood.
[31] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[32] D. Vaux,et al. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[33] A T Look,et al. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. , 1991, Genes & development.
[34] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[35] R. Parmley,et al. Pre-B cell leukemia associated with chromosome translocation 1;19. , 1984, Blood.
[36] F. Alt,et al. IgH enhancer‐mediated deregulation of N‐myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c‐myc expression. , 1989, The EMBO journal.
[37] P Chambon,et al. Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.
[38] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[39] S. Korsmeyer,et al. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.
[40] T. Rabbitts. Translocations, master genes, and differences between the origins of acute and chronic leukemias , 1991, Cell.
[41] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[42] M. Loken,et al. Simultaneous analysis of DNA content and surface antigens in human bone marrow. , 1988, Cytometry.
[43] A. W. Harris,et al. The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.
[44] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[45] S. Korsmeyer,et al. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.
[46] I. Weissman,et al. T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages , 1990, The Journal of experimental medicine.
[47] A. Berns,et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.
[48] G. Sclar,et al. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma , 1992, Molecular and cellular biology.
[49] A. Wyllie,et al. Cell death: the significance of apoptosis. , 1980, International review of cytology.
[50] D. Baltimore,et al. Introduction of a μ immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody , 1984, Cell.
[51] S. Cory,et al. Transgenic models of tumor development. , 1991, Science.